hat
Fiona Reddington, tèt rechèch kansè UK a nan rechèch popilasyon, di: "Efè posib Aspirin la sou kansè yo se kaptivan, e nou espere ke sa a jijman pral ban nou yon repons klè sou si ou pa dwòg la ede sispann kèk kansè vini tounen.
eng
Fiona Reddington, Cancer Research UK’s head of population research, said: “Aspirin’s possible effects on cancer are fascinating, and we hope this trial will give us a clear answer on whether or not the drug helps stop some cancers coming back.